TY - JOUR T1 - Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations JF - bioRxiv DO - 10.1101/009878 SP - 009878 AU - Özgün Babur AU - Mithat Gönen AU - Bülent Arman Aksoy AU - Nikolaus Schultz AU - Giovanni Ciriello AU - Chris Sander AU - Emek Demir Y1 - 2014/01/01 UR - http://biorxiv.org/content/early/2014/10/02/009878.abstract N2 - Recent cancer genome studies have identified numerous genomic alterations in cancer genomes. It is hypothesized that only a fraction of these genomic alterations drive the progression of cancer – often called driver mutations. Current sample sizes for cancer studies, often in the hundreds, are sufficient to detect pivotal drivers solely based on their high frequency of alterations. In cases where the alterations for a single function are distributed among multiple genes of a common pathway, however, single gene alteration frequencies might not be statistically significant. In such cases, we expect to observe that most samples are altered in only one of those alternative genes because additional alterations would not convey an additional selective advantage to the tumor. This leads to a mutual exclusion pattern of alterations, that can be exploited to identify these groups.We developed a novel method for the identification of sets of mutually exclusive gene alterations in a signaling network. We scan the groups of genes with a common downstream effect, using a mutual exclusivity criterion that makes sure that each gene in the group significantly contributes to the mutual exclusivity pattern. We have tested the method on all available TCGA cancer genomics datasets, and detected multiple previously unreported alterations that show significant mutual exclusivity and are likely to be driver events. ER -